Tricuspid annular plane systolic excursion/pulmonary arterial systolic pressure ratio as a predictor of outcome in acute heart failure

##plugins.themes.academic_pro.article.sidebar##

Published Jan 2, 2025
https://doi.org/10.62438/tunismed.v103i1.5365
Download
pdf
Vol. 103 No. 1 (2025): Tunis Med Jan 2025

##plugins.themes.academic_pro.article.main##

Saoussen Antit
Department of Cardiology, Security forces hospital, La Marsa, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunisia
Amal Mrabet
Department of Cardiology, Security forces hospital, La Marsa, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunisia
Marwa Fathi
Department of Cardiology, Security forces hospital, La Marsa, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunisia
Ridha Fekih
Department of Cardiology, Security forces hospital, La Marsa, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunisia
Elhem Boussabeh
Department of Cardiology, Security forces hospital, La Marsa, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunisia
Lilia Zakhama
Department of Cardiology, Security forces hospital, La Marsa, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunisia

Abstract

 


Introduction Acute heart failure (AHF) is a life-threatening condition that requires swift diagnosis and tailored management to enhance patient outcomes. In the pursuit of more precise prognostic indicators, Tricuspid Annular Plane Systolic Excursion (TAPSE) and Pulmonary Arterial Systolic Pressure (PASP) have emerged as potential significant advancements. The TAPSE/PASP ratio, a novel parameter, has recently gained attention as a promising predictor of outcomes in acute heart failure.


Aim: This study delves into the significance of TAPSE/PASP as a predictive tool, shedding light on its potential to revolutionize the landscape of AHF management.


Methods: We included 152 patients with AHF. Echocardiographic evaluation for left ventricle systolic and diastolic function was performed at the time of admission. RV functions were evaluated by calculating the following (TAPSE, PASP, TAPSE/PASP ratio). Data were analyzed to find the predictors of mortality and/or rehospitalization.


Results: The TAPSE/PASP ratio emerged as a significant independent predictor of clinical outcomes in AHF patients (HR=2.6; 95%CI: 1.04-6.47; p=0.04). Furthermore, it was the sole predictor of rehospitalization for AHF (HR=3.97; 95%CI: 1.38-11.40; p=0.01). It also independently predicted all-cause mortality in AHF, with an HR of 2.73 (95% CI: 1.25-9.12; p=0.03). When evaluating its predictive accuracy, the TAPSE/PASP ratio with a cutoff value <0.35 mm/mmHg demonstrated a sensitivity of 65%, specificity of 70%, and an area under the receiver operating characteristic curve of 0.70 for forecasting adverse outcomes.


Conclusion: The non-invasive TAPSE/PASP ratio is an independent predictor of mortality and /or rehospitalization in patients with acute heart failure.

Keywords:

TAPSE/PASP ratio, mortality, rehospitalization, acute heart failure

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

References

  1. Metra M, Teerlink Jr. Heart Failure. Lancet. 2017; 390:1981–95. doi: 10.1016/S0140-6736(17)31071-1.
  2. Crespo-Leiro Mg, Anker Sd, Maggioni Ap, Coats Aj, Filippatos G, Ruschitzka F, et al. European society of cardiology heart failure long-term registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions. Eur J Heart Fail. 2016; 18:613–25. doi: 10.1002/ejhf.566.
  3. De Groote P, Fertin M,Goéminne C, Petyt G, Peyrot S, Foucher-Hossein C, et al. Right ventricular systolic function for risk stratification in patients with stable left ventricular systolic dysfunction: comparison of radionuclide angiography to echo doppler parameters. Eur Heart J. 2012; 33:2672–9. doi: 10.1093/eurheartj/ehs080.
  4. Damy T, Viallet C, Lairez O, Deswarte G, Paulino A, Maison P, et al. Comparison of four right ventricular systolic echocardiographic parameters to predict adverse outcomes in chronic heart failure. Eur J Heart Fail. 2009; 11:818–24. doi: 10.1093/eurjhf/hfp111.
  5. Damy T, Kallvikbacka-Bennett A, Goode K, Khaleva O, Lewinter C,Hobkirk J,Nikitin Np, Dubois-Rande Jl,Hittinger L, Clark Al, Cleland Jg. Prevalence of, associations with, and prognostic value of tricuspid annular plane systolic excursion (TAPSE) among out-patients referred for the evaluation of heart failure. J Card Fail 18: 216 –225, 2012. doi: 10.1016/j.cardfail.2011.12.003.
  6. Dini Fl, Conti U, Fontanive P, Andreini D, Banti S, Braccini L, De Tommasi Sm. Right ventricular dysfunction is a major predictor of outcome in patients with moderate to severe mitral regurgitation and left ventricular dysfunction. Am Heart J 154: 172–179, 2007. doi: 10.1016/j.ahj.2007.03.033.
  7. Dini Fl, Fontanive P, Panicucci E, Andreini D, Chella P, De Tommasi Sm. Prognostic significance of tricuspid annular motion and plasma nt-probnp in patients with heart failure and moderate-to-severe functional mitral regurgitation. Eur J Heart Fail 10: 573–580, 2008. doi: 10.1016/j.ejheart.2008.04.003.
  8. Kjaergaard J, Akkan D, Iversen Kk, Kober L, Torp-Pedersen C, Hassager C. Right ventricular dysfunction as an independent predictor of short- and long-term mortality in patients with heart failure. Eur J Heart Fail 9: 610 –616, 2007. doi: 10.1016/j.ejheart.2007.03.001.
  9. Guazzi M, Borlaug Ba. Pulmonary hypertension due to left heart disease. Circulation 126: 975–990, 2012. doi: 10.1161/CIRCULATIONAHA.111.085761.
  10. Guazzi M, Galie N. Pulmonary hypertension in left heart disease. Eur Respir J 21: 338 –346, 2012. doi: 10.1183/09059180.00004612.
  11. Ghio S, Recusani F, Klersy C, Sebastiani R, Laudisa Ml, Campana C, Gavazzi A, Tavazzi L. Prognostic usefulness of the tricuspid annular plane systolic excursion in patients with congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. Am J Cardiol 85: 837–842, 2000. doi: 10.1016/s0002-9149(99)00877-2.
  12. Shalaby A, Voigt A, El-Saed A, Saba S. Usefulness of pulmonary artery pressure by echocardiography to predict outcome in patients receiving cardiac resynchronization therapy heart failure. Am J Cardiol 101: 238 – 241, 2008. doi: 10.1016/j.amjcard.2007.07.064.
  13. Bursi F, Mcnallan SM, Redfield MM, Nkomo VT, Lam CS, Weston SA, et al. Pulmonary Pressures And Death In Heart Failure: A Community Study. J Am Coll Cardiol 59: 222–231, 2012. doi: 10.1016/j.jacc.2011.06.076.
  14. Lam CS, Roger VL, Rodeheffer RJ, Borlaug BA, Enders FT, Redfield MM. Pulmonary Hypertension in heart failure with preserved ejection fraction: a community-based study. J Am Coll Cardiol 53: 1119 –1126, 2009. doi: 10.1016/j.jacc.2008.11.051.
  15. Guazzi M, Bandera F, Pelissero G, Castelvecchio S, Menicanti L, Ghio S, et al. Tricuspid annular plane systolic excursion and pulmonary arterial systolic pressure relationship in heart failure: an index of right ventricular contractile function and prognosis. Am J Physiol-Heart Circ Physiol. 2013;305:H1373–81. doi: 10.1152/ajpheart.00157.2013. Epub 2013 Aug 30.
  16. Spruijt OA, De Man FS, Groepenhof H, Oosterveer F, Westerhof N, Vonk-Noordegraaf A, et al. The effects of exercise on right ventricular contractility and right ventricular-arterial coupling in pulmonary hypertension. Am J Respir Crit Care Med. 2015. doi: 10.1164/rccm.201412-2271OC.
  17. Bragança B, Trêpa M, Santos R, Silveira I, Fontes-Oliveira M, Sousa Mj, et al. Echocardiographic assessment of right ventriculo-arterial coupling: clinical correlations and prognostic impact in heart failure patients undergoing cardiac resynchronization therapy. J Cardiovasc Imaging. 2020; 28:109. doi: 10.4250/jcvi.2019.0094.
  18. Ghio S, Guazzi M, Scardovi Ab, Klersy C, Clemenza F, Carluccio E, et al. Different correlations but similar prognostic implications for right ventricular dysfunction in heart failure patients with reduced or preserved ejection fraction. Eur J Heart Fail. 2017; 19:873–9. doi: 10.1002/ejhf.664.
  19. Guazzi M, Dixon D, Labate V, Beussink-Nelson L, Bandera F, Cuttica Mj, et al. RV contractile function and its coupling to pulmonary circulation in heart failure with preserved ejection fraction. JACC Cardiovasc Imaging. 2017;10 :1211–21. doi: 10.1016/j.jcmg.2016.12.024.
  20. Santas E, Palau P, Guazzi M, De La Espriella R, Miñana G, Sanchis J, et al. Usefulness of right ventricular to pulmonary circulation coupling as an indicator of risk for recurrent admissions in heart failure with preserved ejection fraction. Am J Cardiol. 2019; 124:567–72. doi: 10.1016/j.amjcard.2019.05.024.
  21. Nie L, Li J, Zhang S, Dong Y, Xu M, Yan M, et al. Correlation between right ventricular–pulmonary artery coupling and the prognosis of patients with pulmonary arterial hypertension. Medicine. 2019;98: E17369. Https:// Doi.Org/10.1097/Md.0000000000017369.
  22. Vriz O, Pirisi M, Bossone E, Fadl Elmula Fem, Palatini P, Naeije R. Right ventricular–pulmonary arterial uncoupling in mild-to-moderate systemic hypertension. J Hypertens. 2020; 38:274–81. doi: 10.1097/HJH.0000000000002238.
  23. Ristow B, Ali S, Whooley MA, Schiller NB. Usefulness of left atrial volume index to predict heart failure hospitalization and mortality in ambulatory patients with coronary heart disease and comparison to left ventricular ejection fraction (from the heart and soul study). Am J Cardiol. 2008; 102:70–6. doi: 10.1016/j.amjcard.2008.02.099.
  24. Antit S, Iddir S, Triki M, Fekih R, Bahri K, Bousnina S, et al. Prognostic value of the echocardiographic ratio tricuspid annular plane systolic excursion / pulmonary arterial systolic pressure in acute pulmonary embolism. Tunis Med. 2024 May 5;102(5):315-320.
  25. Mcdonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 21 Sept 2021;42(36):3599‑726. doi: 10.1093/eurheartj/ehab368.
  26. Park J, Park JJ, Park J, Cho G. Prognostic value of biventricular strain in risk stratifying in patients with acute heart failure. J Am Heart Assoc. 2 Oct 2018;7(19): E009331. doi: 10.1161/JAHA.118.009331.
  27. Rudski LG, Lai WW, Aflalo J, Hua L, Handschumacher MD, Chandrasekaran K, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society Echocardiography endorsed by the european Association of Echocardiography, a registered branch of the European Society Cardiology, and the Canadian Eociety of echocardiography. J Am Soc Echocardiogr. 2010; 23:685–713. doi: 10.1016/j.echo.2010.05.010.
  28. Parasuraman S, Walker S, Loudon BL, Gollop ND, Wilson AM, Lowery C, et al. Assessment of pulmonary artery pressure by echocardiography-a comprehensive review. Int J Cardiol Heart Vasc. 2016; 12:45–51. doi: 10.1016/j.ijcha.2016.05.011.
  29. Fortuni F, Butcher SC, Dietz MF, Van Der Bijl P, Prihadi EA, De Ferrari GM, et al. Right ventricular-pulmonary arterial coupling in secondary tricuspid regurgitation. Am J Cardiol. 2021; 148:138–45. doi: 10.1016/j.amjcard.2021.02.037.
  30. Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2022;43(7):561‑632. doi: 10.1093/eurheartj/ehab395.
  31. Crespo-Leiro MG, Anker SD, Maggioni AP, Coats AJ, Filippatos G, Ruschitzka F, et al. European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions. Eur J Heart Fail. 2016;18:613–25. doi: 10.1002/ejhf.566.
  32. Farmakis D, Parissis J, Lekakis J, Filippatos G. Acute heart failure: epidemiology, risk factors, and prevention. Revista Española De Cardiología (English Edition). 2015; 68:245–8. doi: 10.1016/j.rec.2014.11.004.
  33. Rosenkranz S, Gibbs JS, Wachter R, De Marco T, Vonk-Noordegraaf A, Vachiéry Jl. Left ventricular heart failure and pulmonary hypertension. Eur Heart J 2016 Mar 21;37(12):942-54. doi: 10.1093/eurheartj/ehv512.
  34. Vachiéry JL, Adir Y, Barberà JA, Champion H, Coghlan JG, Cottin V, et al. Pulmonary hypertension due to left heart diseases. J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D100-8. doi: 10.1016/j.jacc.2013.10.033.
  35. Vonk-Noordegraaf A, Haddad F, Chin KM, Forfia PR, Kawut SM, Lumens J, et al. Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology. J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D22-33. doi: 10.1016/j.jacc.2013.10.027.
  36. Todaro MC, Carerj S, Zito C, Trifrò MP, Consolo G, Khandheria B. Echocardiographic evaluation of right ventricular-arterial coupling in pulmonary hypertension. Am J Cardiovasc Dis. 2020;10(4):272–283.
  37. Vanderpool RR, Pinsky MR, Naeije R. RV-pulmonary arterial coupling predicts outcome in patients referred to pulmonary hypertension. Heart. 2015; 101:37–43. doi: 10.1136/heartjnl-2014-306142.
  38. Tello K, Wan J, Dalmer A, Vanderpool R, Ghofrani HA, Naeije R, et al .Validation of the tricuspid annular plane systolic excursion/systolic pulmonary artery pressure ratio for the assessment of right ventricular-arterial coupling in severe pulmonary hypertension. Circ Cardiovasc Imaging. 2019 Sep;12(9):e009047. doi: 10.1161/CIRCIMAGING.119.009047.
  39. Stassen J, Galloo X, Hirasawa K, Chimed S, Marsan NA, Delgado V, et al .Right ventricular-pulmonary artery coupling in cardiac resynchronization therapy: evolution and prognosis. ESC Heart Failure 2022 Jun;9(3):1597-1607. doi: 10.1002/ehf2.13857.
  40. Guazzi M, Dixon D, Labate V, Beussink-Nelson L, Bandera F, Cuttica MJ, et al. RV contractile function and its coupling to pulmonary circulation in heart failure with preserved ejection fraction: stratification of clinical phenotypes and outcomes. JACC Cardiovasc. 2017 Oct;10(10 Pt B):1211-1221. doi: 10.1016/j.jcmg.2016.12.024.
  41. Iacoviello M, Monitillo F, Citarelli G, Leone M, Grande D, Antoncecchi V, et al. Right ventriculo-arterial coupling assessed by two-dimensional strain: a new parameter of right ventricular function independently associated with prognosis in chronic heart failure patients. Int J Cardiol 2017 Aug 15;241:318-321. doi: 10.1016/j.ijcard.2017.04.051.
  42. Brener MI, Grayburn P, Lindenfeld J, Burkhoff D, Liu M, Zhou Z, et al. Right Ventricular-Pulmonary Arterial Coupling in Patients With HF Secondary MR: Analysis From the COAPT Trial. JACC Cardiovasc Interv. 2021 Oct 25;14(20):2231-2242. doi: 10.1016/j.jcin.2021.07.047.
  43. Falletta C, Clemenza F, Klersy C, Agnese V, Bellavia D, Di Gesaro G, et al. Additive value of biomarkers and echocardiography to stratify the risk of death in heart failure patients with reduced ejection fraction. Cardiol Res Pract 2019:1824816. doi: 10.1155/2019/1824816.
  44. Santas E, De la Espriella R, Chorro FJ, Palau P, Miñana G, Heredia R, et al. Right ventricular dysfunction staging system for mortality risk stratification in heart failure with preserved ejection fraction. J Clin Med 2020 Mar 18;9(3):831. doi: 10.3390/jcm9030831.
  45. Schmeisser A, Rauwolf T, Groscheck T, Kropf S, Luani B, Tanev I, et al. Pressure-volume loop validation of TAPSE/PASP for right ventricular arterial coupling in heart failure with pulmonary hypertension. Eur Heart J Cardiovasc Imaging. 2021 Jan 22;22(2):168-176. doi: 10.1093/ehjci/jeaa285.
  46. Karam N, Stolz L, Orban M, Deseive S, Praz F, Kalbacher D, et al. Impact of Right Ventricular Dysfunction on Outcomes After Transcatheter Edge-to-Edge Repair for Secondary Mitral Regurgitation. JACC Cardiovasc Imaging. 2021 Apr;14(4):768-778. doi: 10.1016/j.jcmg.2020.12.015.
  47. Vonk Noordegraaf A, Westerhof BE, Westerhof N. The Relationship Between the Right Ventricle and its Load in Pulmonary Hypertension. J Am Coll Cardiol. 2017 Jan 17;69(2):236-243. doi: 10.1016/j.jacc.2016.10.047.
  48. Jentzer JC, Anavekar NS, Reddy YNV, Murphree DH, Wiley BM, Oh JK, et al. Right Ventricular Pulmonary Artery Coupling and Mortality in Cardiac Intensive Care Unit Patients. J Am Heart Assoc. 2021 Apr 6;10(7):e019015. doi: 10.1161/JAHA.120.019015.
  49. Naseem M, Alkassas A, Alaarag A. Tricuspid annular plane systolic excursion/pulmonary arterial systolic pressure ratio as a predictor of in-hospital mortality for acute heart failure. BMC Cardiovasc Disord. 2022 Sep 17;22(1):414. doi: 10.1186/s12872-022-02857-6.
  50. Jentzer JC, Mathier MA. Pulmonary Hypertension in the Intensive Care Unit. J Intensive Care Med. 2016 Jul;31(6):369-85. doi: 10.1177/0885066615583652.
  51. Harjola VP, Mebazaa A, Čelutkienė J, Bettex D, Bueno H, Chioncel O, et al. Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology. Eur J Heart Fail. 2016 Mar;18(3):226-41. doi: 10.1002/ejhf.478.
  52. Konstam MA, Kiernan MS, Bernstein D, Bozkurt B, Jacob M, Kapur NK, et al. American Heart Association Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; and Council on Cardiovascular Surgery and Anesthesia. Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2018 May 15;137(20):e578-e622. doi: 10.1161/CIR.0000000000000560.